Cochlear, the global leader in implantable hearing solutions, today launched the Cochlear™ Nucleus® Nexa™ System – the world's first ...

UBS has upgraded its rating on hearing implant company Cochlear, expecting new product releases to support ...

Macquarie has released a new note on Cochlear following the company's FY25 profit guidance change. The post Does Macquarie ...

Cochlear could be an ASX share to buy and hold for growth investors. It is the global leader in implantable hearing solutions ...

More news: Cochlear shares were trading higher on Thursday morning after initially sinking at market open on the back of the hearing implant company's downgrade of its full-year guidance. The company ...

In morning trade, the hearing implant leader's shares are down 9% to $246.52. Cochlear shares sink on guidance downgrade Investors have been hitting the sell button today after the company ...

Cochlear’s new implant system offers direct streaming of phone calls and memory settings. The Aussie biotech has warned on its business in developed markets as it expects a turnaround in ...

Cochlear’s new implant system offers direct streaming of phone calls and memory settings. The Aussie biotech has warned on its business in developed markets as it expects a turnaround in ...

Slower-than-expected sales growth over the past few months has led hearing implants giant Cochlear to cut its FY25 underlying profit expectations. Read Today's Paper Tributes Rewards ...

Slower-than-expected sales growth over the past few months has led hearing implants giant Cochlear to cut its FY25 underlying profit expectations. ... The Cochlear Nucleus Nexa System. Picture ...

These conditions can prevent the use of cochlear implants, the standard treatment for many with hearing loss. Auditory brainstem implant (ABI) A device that restores hearing by electrically ...